Health Research, In Plain English • 5,828 Stories

Medical breakthroughs, translated for real life.

Every story explains a peer-reviewed clinical trial or medical journal report at a clear, 8th-grade reading level—with 15-second takeaways, participant counts, Study Rigor Scores, and a direct link to the formal paper.

All Research Stories Phase III Randomized Trial (3,355) Randomized Controlled Trial (1,799) Meta-Analysis (566) Peer-Reviewed Journal (Clinical Trials) (39) FDA Drug Recall (Class II) (15) Completed Human Clinical Trial (NCT) (15) FDA Safety Alert (13) FDA Recall (12) Peer-Reviewed Journal (Longevity & Biotech) (8) Clinical Trial (4) Clinical Pharmacology Review (1) Systematic Review (1)

Live Journal & Safety Desks: JAMA Network New England Journal of Medicine The Lancet BMJ Recent Research Nature Medicine FDA MedWatch Safety Alerts FDA Drug Recalls

Clinical Trial • Scientific reports • 2025-05-08

Can This Approach Help? Inside the Latest Research on Rosuvastatin 10 mg plus ezetimibe versus rosuvastatin 20 mg in atherosclerotic

Incidence of total side effects was lower in the combination groups than in the high-intensity rosuvastatin group (p = 0.048).

Read Plain-English Story | Formal Study: “Comparison of rosuvastatin 10 mg plus ezetimibe versus rosuvastatin 20 mg in atherosclerotic cardiovascular disease and type 2 diabetes”

Rigor 72/100

Formal Study (PMID #40341101)

Clinical Trial • Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists • 2024-09-15

Can This Approach Help? Inside the Latest Research on Ambulatory Blood Pressure Parameters Among Men With Hypogonadism Treated With

A meaningful effect of 16-week TTS treatment on 24-hour average SBP among men with hypogonadism could not be ruled out based on the study's noninferiority criterion.

Read Plain-English Story | Formal Study: “Ambulatory Blood Pressure Parameters Among Men With Hypogonadism Treated With Testosterone Transdermal Therapy”

N = 62 Rigor 72/100

Formal Study (PMID #38876182)

Clinical Trial • BioMed research international • 2020-01-15

Can This Approach Help? Inside the Latest Research on Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of

BTA is a safe and effective therapeutic strategy for the treatment of AGA without adverse effects, and BTA combined with FNS exhibited a superior therapeutic effect than BTA alone.

Read Plain-English Story | Formal Study: “Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia”

N = 63 Rigor 72/100

Formal Study (PMID #32802833)

Clinical Trial • American journal of hypertension • 2019-09-24

New Insights on 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed: What a 231-Participant Study Found

Office systolic BP reduction with L/A was not inferior to L/H after 4 week's treatment.

Read Plain-English Story | Formal Study: “Comparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central Study”

N = 231 Rigor 78/100

Formal Study (PMID #31099387)